Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...
For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...
MINNEAPOLIS — Switching candidates for implantable cardioverter-defibrillator (ICD) implantation to a dual-function device that also modulates cardiac contractility was associated with successful ...
Please provide your email address to receive an email when new articles are posted on . “Prior research has established the subcutaneous ICD as a reasonable alternative to the transvenous ICD in ...
Analysis results revealed racial and sex disparities among patients with hypertrophic cardiomyopathy who receive implantable cardioverter-defibrillator (ICD) devices. Among patients hospitalized with ...
A cardiologist and electrophysiologist familiar with Boston Scientific's novel products bets one has a very bright future ahead. Arundhati Parmar Boston Scientific had a great 2014, and many Wall ...
A new Mayo Clinic study questions the benefit of implantable cardioverter-defibrillator use to treat patients with transthyretin cardiac amyloidosis. For patients with transthyretin cardiac ...
If you have hypertrophic cardiomyopathy (HCM), and especially if you have obstructive HCM that reduces blood flow out of your heart, you and your doctor may discuss ways to lower your risk of sudden ...
CHICAGO (Reuters) - Boston Scientific Corp's new leadless implantable heart defibrillator, hailed by some as a breakthrough, should be used on a limited basis until more data are collected, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results